DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)



company name or ticker

Amarin Corp. Quietly Gains Market Share, May Be Helped By Congress

Why Amarin Corporation (AMRN) Could Be Positioned for a Slump - Tale of the Tape

Why Amarin Corporation (AMRN) Could Be Positioned for a Slump - Tale of the Tape

Which of These Growth Stocks Is Most Worthy of Your Money?

Amarin Corp. and Arena Pharmaceuticals were once high-flying biotech stocks. Since the commercial launch of their respective flagship products, though, their shares have fallen in a big way. In this article, I consider which stock has the better chance of recapturing its former glory going forward.

Amarin: Apparent Q1 Revenue Miss Mostly Due To Revenue Recognition And Shipment Timing

Amarin's Smart 1st Amendment Strategy

Amarin's (AMRN) CEO John Thero on Q1 2015 Results - Earnings Call Transcript

Amarin Hampered By Rising Operational Costs But Could Be Saved By First Amendment

European ADRs Fractionally Higher as Pharmaceuticals Stocks Gain

In Case You Missed It, This New Study Suggests America Is a Nation of Couch Potatoes

Put plainly, we as a nation are becoming increasing sedentary. Don't believe me? Take a look at the findings of this latest report from the Physical Activity Council.

Amarin May Struggle Some More Amid Biotech Selloff

See More Articles...